Bionorica SE signed a sale and purchase agreement to acquire LOMA Holding GmbH from Daicel Corporation (TSE:4202) on March 31, 2023. Lomapharm will become a 100% subsidiary of Bionorica upon completion of the transaction. Michael Burian and team of Gleiss Lutz acted as legal advisors to Daicel Corporation.

Bionorica SE completed the acquisition of LOMA Holding GmbH from Daicel Corporation (TSE:4202) on March 31, 2023.